MJA
MJA

Variable uptake of recommended interventions to reduce mother-to-child transmission of HIV in Australia, 1982–2005

Med J Aust 2008; 189 (3): 151-154.

Summary

Objective: To analyse the uptake of interventions known to reduce the risk of perinatal HIV transmission among Australian women with HIV infection (who knew their HIV status before delivery), and identify predictors of uptake.

Design: Retrospective analysis of perinatal HIV surveillance data in Australia.

Patients: Women reported as having HIV infection and having given birth to a child (1982–2005) were identified through three mechanisms: an informal network of clinicians (1982–1993); an active surveillance program through paediatricians (since 1993); and state health department reports of children born to women newly diagnosed with HIV (since 1995).

Main outcome measures: Uptake of interventions — avoidance of breastfeeding (after 1985), use of zidovudine during pregnancy (after 1994), and elective caesarean section (after 1999). Factors associated with uptake of these interventions were identified by univariate and multivariate analyses.

Results: 367 live births were reported in 291 women with HIV infection. Among the subgroup diagnosed with HIV infection before delivery, 4/255 (1.6%) elected to breastfeed (post 1985), 44/185 (24%) did not receive zidovudine (after 1994), and 41/118 (35%) did not have an elective caesarean section (after 1999). In multivariate analysis, there were significant differences in uptake of zidovudine and elective caesarean section according to year of birth and state in which the birth took place.

Conclusion: In Australia between 1982 and 2005, uptake of interventions to reduce mother-to-child transmission of HIV was high. There were significant differences associated with use of zidovudine and mode of delivery according to location of delivery and year of birth.

  • Michelle L Giles1,2,0,3
  • Ann M McDonald4
  • Elizabeth J Elliott5,6,7
  • John B Ziegler8,9
  • Margaret E Hellard2,3
  • Sharon R Lewin1,3
  • John M Kaldor4

  • 1 Department of Medicine, Monash University, Melbourne, VIC.
  • 2 Centre for Epidemiology and Population Health Research, Burnet Institute, Melbourne, VIC.
  • 3 Infectious Disease Unit, Alfred Hospital, Melbourne, VIC.
  • 4 National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW.
  • 5 Discipline of Paediatrics and Child Health, University of Sydney, Sydney, NSW.
  • 6 Children’s Hospital at Westmead, Sydney, NSW.
  • 7 Australian Paediatric Surveillance Unit, Sydney, NSW.
  • 8 Department of Immunology, Sydney Children’s Hospital, Sydney, NSW.
  • 9 School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW.


Acknowledgements: 

The activities of the APSU are supported by the Australian Government Department of Health and Ageing (National Health and Medical Research Council [NHMRC] Enabling Grant No. 402784 and NHMRC Practitioner Fellowship No. 457084 [Elizabeth Elliott]); Discipline of Paediatrics and Child Health, University of Sydney; and the Royal Australasian College of Physicians.

Competing interests:

Sharon Lewin has received funding to attend meetings by Gilead, Pfizer, Roche and Boehringer. She received educational grants from Roche and has sat on advisory boards for Roche and Pfizer.

  • 1. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2006. Sydney: NCHECR; Australian Institute of Health and Welfare, 2006.
  • 2. Brocklehurst P. Interventions for reducing the risk of mother-to-child transmission of HIV infection Cochrane Database Syst Rev 2002; (1): CD000102.
  • 3. Ziegler JB, Cooper DA, Johnson RD, et al. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985; 1: 896-898.
  • 4. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-1180.
  • 5. The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomized clinical trial. Lancet 1999; 353: 1035-1039.
  • 6. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. N Engl J Med 1999; 340: 977-987.
  • 7. McDonald AM, Cruickshank M, Ziegler JB, et al. Perinatal exposure to HIV in Australia, 1982–1994. Med J Aust 1997; 166: 77-80.
  • 8. McDonald AM, Li Y, Cruickshank MA, et al. Use of interventions for reducing mother-to-child transmission of HIV in Australia. Med J Aust 2001; 174: 449-452.
  • 9. Ioannidis JPA, Abrams EL, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads < 1000 copies/mL. J Infect Dis 2001; 183: 539-545.
  • 10. Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. November 2, 2007. Washington, DC: United States Department of Health and Human Services, 2007.
  • 11. British HIV Association. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. London: BHIVA, 2005. http://www.bhiva.org/files/file1030325.pdf (accessed Mar 2008).
  • 12. Centers for Disease Control and Prevention (CDC). Achievements in public health: reduction in perinatal transmission of HIV infection — United States, 1985–2005. MMWR Morb Mortal Wkly Rep 2006; 55: 592-597.
  • 13. Dominguez KL, Lindegren ML, D’Almada PJ, et al. Increasing trend of cesarean deliveries in HIV-infected women in the United States from 1994 to 2000. J Acquir Immune Defic Syndr 2003; 33: 232-238.
  • 14. Lyall EG, Stainsby C, Taylor GP, et al. Review of uptake of interventions to reduce mother to child transmission of HIV by women aware of their HIV status. BMJ 1998; 316: 268-270.
  • 15. Hall SM, Nicoll A. The British Paediatric Surveillance Unit — a pioneering method for investigating the less common disorders of childhood. Report of a seminar held in June 1995. Child Care Health Dev 1998; 24: 129-143.
  • 16. Knowles RL, Smith A, Lynn R, Rahi JS; British Paediatric Surveillance Unit. Using multiple sources to improve and measure case ascertainment in surveillance studies: 20 years of the British Paediatric Surveillance Unit. J Public Health (Oxf) 2006; 28: 157-165.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article